[
    {
        "other_ids": [
            {
                "name": "Study Protocol Other Identifier",
                "value": "s15-01200"
            }
        ],
        "amendment_date": "2021-01-27",
        "keywords": null,
        "dcp_id": null,
        "interventional_model": "Parallel",
        "lead_org": "NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "Histologically or cytologically confirmed adenocarcinoma of the breast with unresectable or metastatic disease"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "Most recent tumor biopsy or surgical resection specimen must be either estrogen receptor (ER) positive, progesterone receptor (PgR) positive, or both, as defined by immunohistochemistry (IHC) >= 1% (as per the American Society of Clinical Oncology-College of American Pathologists [ASCO-CAP] guidelines)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "Human epidermal growth factor receptor 2 (HER2)-negative breast cancer defined as a negative in situ hybridization test or an IHC status of 0 or 1+; if IHC is 2+ (i.e. indeterminate), a negative in situ hybridization (fluorescence in situ hybridization [FISH], chromogenic in situ hybridization [CISH], or silver in situ hybridization [SISH]) test is required by local laboratory testing; (as per the ASCO-CAP guidelines)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "Postmenopausal status or receiving ovarian ablation with a gonadotropin-releasing hormone (GnRH) agonist such as goserelin\r\n* Postmenopausal status is defined by any one of the following criteria:\r\n** Prior bilateral oophorectomy\r\n** Age >= 60 years\r\n** Age < 60 and amenorrhea for 12 or more months (in the absence of chemotherapy, tamoxifen, toremifene, or ovarian suppression) and follicle-stimulating hormone (FSH), luteinizing hormone (LH), and estradiol in the postmenopausal range per local normal\r\n* If the patient does not meet criteria for postmenopausal status but is receiving ovarian ablation therapy with a gonadotropin-releasing hormone (GnRH) agonist such as goserelin, the patient is eligible for this study, provided that the GnRH agonist is started at least 2 weeks prior to cycle 1 day 1 (C1D1) of anti-estrogen therapy"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "Have evidence of measurable or unmeasurable disease"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "Eastern Cooperative Group (ECOG) performance status of 0 or 1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "Scenario 1: No prior cdk 4/6 inhibitor (Closed to Accrual); if patient has not previously received letrozole, letrozole will be supplied by Novartis; if previously progressed on letrozole, another aromatase inhibitor that the patient has not previously received is allowed, per standard of care (anastrozole or exemestane, not supplied by study); ribociclib will be supplied by Novartis; if patient has previously received letrozole, anastrozole, and exemestane, (s)he is not eligible; for scenario 1, patients are allowed to have started the aromatase inhibitor within 4 consecutive weeks prior to protocol registration; for instance, it is acceptable for patient who will be treated with letrozole in scenario #1, to have started letrozole within 4 consecutive weeks prior to protocol registration; no prior fulvestrant allowed"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "Scenario 2: the patient must have received an aromatase inhibitor (letrozole, arimidex, exemestane) or tamoxifen or fulvestrant plus palbociclib as standard of care or received a CDK4/6 inhibitor (palbociclib or ribociclib or abemaciclib), and demonstrated evidence of disease progression; if the patient was enrolled in a randomized clinical trial involving ribociclib or abemaciclib or palbociclib (such as the MONALEESA or PALOMA series of trials), then it must be known after study discontinuation and unblinding that the patient received the investigational drug and not placebo; ribociclib or abemaciclib or palbociclib can also be given as standard of care; documentation of progression and duration of response on aromatase inhibitor or tamoxifen plus CDK 4/6 inhibitor should be provided whenever possible; if patient received prior fulvestrant, exemestane must be the hormone therapy backbone in the randomization; if patient received prior exemestane, fulvestrant must be the hormone therapy backbone in the randomization; if neither has been administered, selection of fulvestrant or exemestane in the randomization will be per investigator discretion"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 9,
                    "description": "Absolute neutrophil count >= 1500 per microliter"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 10,
                    "description": "Platelets >= 75,000 per microliter"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 11,
                    "description": "Hemoglobin level >= 8.0 gm/dL on screening complete blood count"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 12,
                    "description": "Potassium and total calcium (corrected only in the case of hypoalbuminemia) within normal limits of the local laboratory (screening values can be rechecked after electrolyte repletion and before the first dose of study medication, if necessary)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 13,
                    "description": "Serum creatinine level =< 1.5 mg/dL or estimated glomerular filtration rate >= 50 mL/min"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 14,
                    "description": "In the absence of liver metastases, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) should be below 2.5 x the upper limit of normal (ULN); if the patient has liver metastases, ALT and AST should be < 5 x ULN"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 15,
                    "description": "Total bilirubin =< 1.5 x ULN; (in patients with well documented Gilbert\u2019s syndrome, total bilirubin =< 3 x ULN with direct bilirubin within normal range)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 16,
                    "description": "International normalized ratio (INR) =< 1.5"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 17,
                    "description": "Written informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization obtained from the subject/legal representative prior to performing any protocol-related procedures"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 18,
                    "description": "Subjects must be willing and able to comply with scheduled visits, treatment schedule, laboratory testing, and other requirements of the study"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 19,
                    "description": "Must be able to swallow ribociclib and oral aromatase inhibitor, such as letrozole or exemestane"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 20,
                    "description": "Patient has a known hypersensitivity to any of the excipients of ribociclib, aromatase inhibitors (such as letrozole) or fulvestrant"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 21,
                    "description": "Active central nervous system (CNS) disease; history of CNS metastases or cord compression is allowable if the patient has been clinically stable for at least 4 weeks since completion of definitive treatment and is off systemic steroids; in the case of brain metastases, the patient must have stable or improved imaging at least 4 weeks after completion of definitive treatment; if there is evidence of active leptomeningeal disease, the patient is ineligible"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 22,
                    "description": "Identified as having visceral crisis, lymphangitic spread, or leptomeningeal carcinomatosis; visceral crisis is not the mere presence of visceral metastases but implies severe organ dysfunction as assessed by symptoms and signs, laboratory studies, and rapid progression of the disease"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 23,
                    "description": "Received more than 1 prior systemic chemotherapy in the unresectable or metastatic setting; if the patient received 1 prior systemic chemotherapy, the patient is eligible; having received prior therapies for breast cancer (such as everolimus or experimental agents) does not affect eligibility for this study"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 24,
                    "description": "Completion of major surgery, chemotherapy, targeted therapy (such as everolimus or experimental agents or radiation within 14 days prior to starting investigational drug or has not recovered from major side effects; there is no required washout period from completion of prior anti-estrogen therapy (either scenario) or prior CDK 4/6 inhibitor (if scenario 2) to initiation of ribociclib/placebo and anti-estrogen on trial"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 25,
                    "description": "Residual acute toxic effects of prior anti-cancer therapy that have not resolved to Common Terminology Criteria for Adverse Events version 4 (CTCAE v.4) grade =< 1; exception to this criterion: patients with grade 1 taxane-induced neuropathy, any grade of alopecia, amenorrhea or other toxicities not considered a safety risk for the patient as per investigator\u2019s discretion, are allowed to enter the study"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 26,
                    "description": "Presence of a concurrent malignancy or malignancy diagnosed within 5 years of randomization, with the exception of basal or squamous cell carcinoma, non-melanomatous skin cancer, curatively resected cervical cancer, localized prostate cancer treated with curative intent, and stage I colorectal cancer treated with curative resection"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 27,
                    "description": "Patient has impairment of gastrointestinal (GI) function or GI disease that may significantly alter the absorption of the study drugs (e.g. ulcerative diseases, uncontrolled nausea, vomiting, diarrhea, malabsorption syndrome, or small bowel resection)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 28,
                    "description": "Patient has a known history of human immunodeficiency virus (HIV) infection (testing not mandatory)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 29,
                    "description": "Clinically significant, uncontrolled heart disease and/or cardiac repolarization abnormality including any of the following:\r\n* History of myocardial infarction (MI), angina pectoris, symptomatic pericarditis, or coronary artery bypass graft (CABG) within 6 months prior to study entry\r\n* Documented cardiomyopathy\r\n* Patient has a known left ventricular fraction (LVEF) < 50% as determined by multiple gated acquisition (MUGA) scan or echocardiogram (ECHO)\r\n* Long QT syndrome or family history of long QT syndrome or family history of idiopathic sudden death or congenital long QT syndrome, or any of the following:\r\n** Risk factors for torsades de pointe (TdP) including uncorrected hypocalcemia, hypokalemia or hypomagnesaemia, history of cardiac failure, or history of clinically significant/symptomatic bradycardia\r\n** Concomitant medications(s) with a known risk to prolong the QT interval and/or known to cause torsades de pointe that cannot be discontinued or replaced by safe alternative medication (e.g. within 5 half-lives or 7 days prior to starting study drug)\r\n** Inability to determine the corrected QT (QTc) interval\r\n* Clinically significant cardiac arrhythmias (e.g., ventricular tachycardia), complete left bundle branch block, high-grade atrioventricular (AV) block (e.g., bifascicular block, Mobitz type II and third degree AV block)\r\n* Systolic blood pressure (SPB) > 160 or < 90 mmHg"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 30,
                    "description": "Corrected QT interval (QTcF) > 450 msec (QT interval using Fridericia\u2019s correction) on screening electrocardiogram; if QTc prolongation is felt to be related to electrolyte imbalance, an electrocardiogram (EKG) can be repeated after correction of electrolytes; mean resting heart rate 50-100 beats per minute (bpm) (determined from ECG)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 31,
                    "description": "The presence of any other concurrent severe and/or uncontrolled medical condition that would, in the investigator or treating physician\u2019s judgment, cause unacceptable safety risks, contraindicate patient participation in the clinical study or compromise compliance with the protocol; this includes uncontrolled infections that could potentially be exacerbated by anti-neoplastic treatment, active untreated or uncontrolled fungal bacterial or viral infections, etc"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 32,
                    "description": "Currently receiving treatment, including medications and herbal preparations with known strong inducers or inhibitors of cytochrome p450 enzymes cytochrome P450 family 3, subfamily A, polypeptide 4/5 (CYP3A4/5) medications that have a narrow therapeutic window and are predominately metabolized through CYP3A4/5 or herbal preparations/medications, dietary supplements, which cannot be discontinued prior to receiving investigational drug; anti-retrovirals, anti-microbials, and anti-arrhythmics are the most common medications that interact with these enzymes"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 33,
                    "description": "Patients who are receiving any other investigational agents concurrently or have received investigational agents within 14 days or 5 half-lives of the compound or active metabolites, whichever is longer before the first dose of the study treatment"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 34,
                    "description": "Patient is concurrently using hormone replacement therapy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 35,
                    "description": "Subject is pregnant or nursing; serum or urine beta-human chorionic gonadotropin (HCG) must be checked in all non-postmenopausal patients or patients of childbearing potential; (fulvestrant is pregnancy category D and CDK4/6 inhibitors have demonstrated teratogenicity/fetotoxicity in animal studies.)"
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": null,
        "detail_description": "PRIMARY OBJECTIVE:\r\nI. To evaluate the progression-free survival (PFS) of fulvestrant or exemestane with or without ribociclib after progression on anti-estrogen therapy plus cyclin-dependent kinase 4/6 inhibitor in patients with hormone receptor positive (HR+), HER2- breast cancer.\r\n\r\nSECONDARY OBJECTIVES:\r\nI. To assess the overall response rate (ORR = complete + partial response rate) and clinical benefit rate (CBR= ORR + stable disease rate at >= 24 weeks of follow up) in the study population in both arms of the trial, post-randomization.\r\nII. To assess the PFS, ORR, CBR, and safety of ribociclib with an aromatase inhibitor in patients with metastatic or unresectable HR+ HER2- breast cancer.\r\nIII. To explore differences in clinical outcome (PFS, ORR, CBR) in patients receiving an aromatase inhibitor plus ribociclib versus (vs.) palbociclib vs. abemaciclib (scenario 1), both prior to randomization and then after continuation of CDK4/6 inhibition. \r\nIV. To evaluate the rates of adverse events and tolerability of the combination of fulvestrant or exemestane with and without ribociclib.\r\nV. To explore potential predictive tumor and blood-based predictive biomarkers.\r\nVI. To assess the impact of the combination therapy vs. fulvestrant or exemestane alone on patient reported global health assessment and quality of life.\r\n\r\nOUTLINE: Patients are assigned to Scenario 1 or Scenario 2.\r\n\r\nScenario 1: Patients receive ribociclib orally (PO) once daily (QD) on days 1-21 and letrozole PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients experiencing disease progression are then assigned to Scenario 2.\r\n\r\nScenario 2: Patients are randomized to 1 of 2 arms.\r\n\r\nArm A: Patients receive ribociclib PO QD on days 1-21. Patients also receive fulvestrant intramuscularly (IM) every 2 weeks for 6 weeks then every 4 weeks or exemestane PO daily on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.\r\n\r\nArm B: Patients receive placebo PO QD on days 1-21 and fulvestrant IM or exemestane PO as in Arm A. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.\r\n\r\nAfter completion of study treatment, patients are followed up at 30 days, then every 12 weeks thereafter.",
        "official_title": "A Randomized Phase II TrIal of Fulvestrant or Exemestane with or without Ribociclib after Progression on Anti-Estrogen Therapy plus Cyclin-Dependent Kinase 4/6 Inhibition in Patients with Unresectable or Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer (MAINTAIN Trial)",
        "_phase_sort_order": 2,
        "collaborators": [
            {
                "name": "National Cancer Institute",
                "functional_role": "FUNDING_SOURCE"
            }
        ],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "Up to 5 years",
                "name": "CBR in patients registered under scenario #1",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 5 years",
                "name": "Clinical benefit rate (CBR)",
                "description": "Will be assessed using RECIST criteria (version 1.1).",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From time interval from when measurement criteria are met for complete or partial response (whichever is first recorded) until the first date that recurrent or progressive disease is objectively documented, assessed up to 5 years",
                "name": "Duration of overall response",
                "description": "Will be assessed using RECIST criteria (version 1.1).",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 5 years",
                "name": "Incidence of adverse events",
                "description": "Will be assessed by CTCAE v 4.0.",
                "type_code": "OTHER_PRE_SPECIFIED"
            },
            {
                "timeframe": "Up to 5 years",
                "name": "Incidence of adverse events",
                "description": "Will be assessed by Common Terminology Criteria for Adverse Events version (CTCAE v) 4.0 in patients registered under scenario #1.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 5 years",
                "name": "Location of distant metastasis",
                "description": null,
                "type_code": "OTHER_PRE_SPECIFIED"
            },
            {
                "timeframe": "Up to 5 years",
                "name": "ORR in patients registered under scenario #1",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 5 years",
                "name": "Overall response rate (ORR)",
                "description": "Will be assessed using Response Evaluation Criteria in Solid Tumors (RECIST) criteria (version 1.1).",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 5 years",
                "name": "PFS",
                "description": "Will be estimated by Kaplan-Meier method and group differences between groups will be assessed using log-rank tests.",
                "type_code": "OTHER_PRE_SPECIFIED"
            },
            {
                "timeframe": "Up to 5 years",
                "name": "PFS in patients registered under scenario #1",
                "description": "Will be estimated by Kaplan-Meier method and group differences between groups will be assessed using log-rank tests.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From time of randomization until objective disease progression (local assessment) or death from any cause, assessed up to 5 years",
                "name": "Progression free survival (PFS)",
                "description": "Kaplan-Meier estimates will be used to calculate medians and 95% confidence intervals for PFS. A one-sided log-rank test will be used to test for a difference in PFS between the two arms.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Up to 5 years",
                "name": "Quality of life",
                "description": "Will be assessed by Patient-Reported Outcomes Measurement Information System (Global Health and PROMIS-29) and EuroQol five-dimensional (EQ-5D)-3L.",
                "type_code": "OTHER_PRE_SPECIFIED"
            },
            {
                "timeframe": "Up to 5 years",
                "name": "Response rates",
                "description": "Will be estimated as the proportion of enrolled patients who achieve response.",
                "type_code": "OTHER_PRE_SPECIFIED"
            },
            {
                "timeframe": "Up to 5 years",
                "name": "Tumor and blood-based predictive biomarkers",
                "description": "Exploratory tumor tissue biomarkers that will be examined to include overexpression or amplification. Serum and plasma will be collected and stored for potential future exploratory analyses. Differences in resistance between those who received ribociclib versus (vs.) palbociclib vs. abemaciclib will be explored.",
                "type_code": "OTHER_PRE_SPECIFIED"
            }
        ],
        "phase": "II",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 3,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT02632045",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "PGR",
                    "PR",
                    "Progesterone Receptor Gene"
                ],
                "nci_thesaurus_concept_id": "C28656",
                "name": "PGR Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C20420",
                    "C54362",
                    "C20103",
                    "C20709"
                ],
                "parents": [
                    "C20709"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ER Alpha Positive",
                    "ER Positive",
                    "ER+",
                    "ER-Alpha Positive",
                    "ERA Positive",
                    "ESR Positive",
                    "ESR1 Positive",
                    "ESRA Positive",
                    "ESTRR Positive",
                    "Estrogen Receptor 1 Positive",
                    "Estrogen Receptor Alpha Positive",
                    "NR3A1 Positive",
                    "Nuclear Receptor Subfamily 3 Group A Member 1 Positive",
                    "Positive",
                    "Positive Estrogen Receptor"
                ],
                "nci_thesaurus_concept_id": "C15492",
                "name": "Estrogen Receptor Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C177692",
                    "C16612",
                    "C3367",
                    "C28656",
                    "C21295",
                    "C16150",
                    "C20420",
                    "C38349",
                    "C54362",
                    "C35682",
                    "C36292",
                    "C20103",
                    "C94299",
                    "C77140",
                    "C20709",
                    "C101267"
                ],
                "parents": [
                    "C101267",
                    "C16150",
                    "C38349"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21281",
                "name": "Enzyme Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Positive",
                    "positive test result"
                ],
                "nci_thesaurus_concept_id": "C35682",
                "name": "Positive Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C77140"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20719",
                "name": "Receptor Tyrosine Kinase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C25870",
                    "C25872",
                    "C20103",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C20103",
                    "C25872"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25870",
                "name": "Transferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21281"
                ],
                "parents": [
                    "C21281"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25871",
                "name": "Phosphotransferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25870",
                    "C16612",
                    "C21281"
                ],
                "parents": [
                    "C25870"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "PgR Status",
                    "Progesterone Receptor"
                ],
                "nci_thesaurus_concept_id": "C16149",
                "name": "Progesterone Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C20420",
                    "C36292",
                    "C16612",
                    "C20709",
                    "C20103",
                    "C94299",
                    "C21295",
                    "C77140",
                    "C54362",
                    "C3367",
                    "C28656"
                ],
                "parents": [
                    "C28656",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER Alpha Status",
                    "ER Status",
                    "ER-Alpha Status",
                    "ERA Status",
                    "ESR Status",
                    "ESR1 Status",
                    "ESRA Status",
                    "ESTRR Status",
                    "Estrogen Receptor",
                    "Estrogen Receptor 1 Status",
                    "Estrogen Receptor Alpha Status",
                    "NR3A1 Status",
                    "Nuclear Receptor Subfamily 3 Group A Member 1 Status"
                ],
                "nci_thesaurus_concept_id": "C16150",
                "name": "Estrogen Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C16612",
                    "C21295",
                    "C20420",
                    "C38349",
                    "C54362",
                    "C36292",
                    "C20103",
                    "C94299",
                    "C77140",
                    "C20709"
                ],
                "parents": [
                    "C38349",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Absent",
                    "LOST",
                    "Loss of Expression",
                    "Negative",
                    "Not Expressed"
                ],
                "nci_thesaurus_concept_id": "C165233",
                "name": "Expression Negative",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C35681",
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C35681"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER and/or PR +",
                    "ER and/or PR Positive",
                    "Estrogen Receptor and/or Progesterone Receptor Positive"
                ],
                "nci_thesaurus_concept_id": "C101267",
                "name": "Hormone Receptor Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C177692",
                    "C16612",
                    "C3367",
                    "C28656",
                    "C21295",
                    "C20420",
                    "C38349",
                    "C54362",
                    "C36292",
                    "C94299",
                    "C77140",
                    "C20103",
                    "C20709",
                    "C35682"
                ],
                "parents": [
                    "C177692",
                    "C28656",
                    "C38349",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2",
                    "Erb-b2 Receptor Tyrosine Kinase 2 Gene",
                    "HER2",
                    "HER2/Neu",
                    "NEU"
                ],
                "nci_thesaurus_concept_id": "C17756",
                "name": "ERBB2 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C20719",
                    "C25870",
                    "C25872",
                    "C20103",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C20719"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Negative"
                ],
                "nci_thesaurus_concept_id": "C35681",
                "name": "Negative Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C94299",
                "name": "Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C77140"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20709",
                "name": "Nuclear Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C20420",
                    "C54362",
                    "C20103"
                ],
                "parents": [
                    "C20103",
                    "C20420"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ERBB2 Negative",
                    "HER-2 Negative",
                    "HER2 Negative"
                ],
                "nci_thesaurus_concept_id": "C68749",
                "name": "HER2/Neu Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C165233",
                    "C16612",
                    "C17756",
                    "C3367",
                    "C21295",
                    "C35681",
                    "C20719",
                    "C25870",
                    "C16152",
                    "C36292",
                    "C25872",
                    "C94299",
                    "C77140",
                    "C20103",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C16152",
                    "C165233",
                    "C17756"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Proto-Oncogene, Transcription Factor"
                ],
                "nci_thesaurus_concept_id": "C20420",
                "name": "Transcription Factor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C54362",
                    "C16612"
                ],
                "parents": [
                    "C54362"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER",
                    "ESR1",
                    "Estrogen Receptor 1 Gene"
                ],
                "nci_thesaurus_concept_id": "C38349",
                "name": "ESR1 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C20420",
                    "C54362",
                    "C20103",
                    "C20709"
                ],
                "parents": [
                    "C20709"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "PGR Positive",
                    "PR Positive",
                    "PR+",
                    "Positive"
                ],
                "nci_thesaurus_concept_id": "C15496",
                "name": "Progesterone Receptor Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C94299",
                    "C54362",
                    "C36292",
                    "C77140",
                    "C20709",
                    "C38349",
                    "C20103",
                    "C20420",
                    "C16149",
                    "C21295",
                    "C101267",
                    "C35682",
                    "C16612",
                    "C3367",
                    "C28656",
                    "C177692"
                ],
                "parents": [
                    "C101267",
                    "C16149",
                    "C28656"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C54362",
                "name": "Transcription Regulation Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25872",
                "name": "Kinase Family Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25870",
                    "C16612",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C25871"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2 Status",
                    "Her2/Neu Value"
                ],
                "nci_thesaurus_concept_id": "C16152",
                "name": "HER2/Neu Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C16612",
                    "C17756",
                    "C21295",
                    "C20719",
                    "C25870",
                    "C36292",
                    "C25872",
                    "C94299",
                    "C77140",
                    "C20103",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C17756",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20103",
                "name": "Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295"
                ],
                "parents": [
                    "C21295"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21295",
                "name": "Ligand Binding Protein Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Expressed",
                    "Expression Detected"
                ],
                "nci_thesaurus_concept_id": "C177692",
                "name": "Expression Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C35682",
                    "C77140"
                ],
                "parents": [
                    "C35682"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": "Efficacy",
        "current_trial_status_date": "2016-05-05",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153238",
                "name": "Metastatic Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C170728",
                    "C4872"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C158752",
                "name": "Unresectable Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4872",
                    "C148124"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Breast Cancer AJCC v7",
                    "Stage IV Breast Cancer AJCC v6",
                    "Stage IV Breast Carcinoma",
                    "Breast Carcinoma Stage IV",
                    "Breast Cancer Stage IV",
                    "Stage IV Breast Cancer AJCC v6 and v7"
                ],
                "nci_thesaurus_concept_id": "C3995",
                "name": "Stage IV Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C90513",
                    "C91230"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Adenocarcinoma of the Breast",
                    "Mammary adenocarcinoma",
                    "Adenocarcinoma of Breast"
                ],
                "nci_thesaurus_concept_id": "C5214",
                "name": "Breast Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4872",
                    "C2852"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Cancer Stage IIIA",
                    "Stage IIIA Breast Carcinoma",
                    "Stage IIIA Breast Cancer AJCC v7",
                    "Breast Carcinoma Stage IIIA"
                ],
                "nci_thesaurus_concept_id": "C7770",
                "name": "Stage IIIA Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C88376"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Breast Carcinoma",
                    "Breast Cancer, Recurrent"
                ],
                "nci_thesaurus_concept_id": "C7771",
                "name": "Recurrent Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7619",
                    "C170726",
                    "C4872"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma Stage IIIB",
                    "Breast Cancer Stage IIIB",
                    "Stage IIIB Breast Cancer AJCC v7",
                    "Stage IIIB Breast Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C7782",
                "name": "Stage IIIB Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C88376"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage III Breast Cancer AJCC v7"
                ],
                "nci_thesaurus_concept_id": "C88376",
                "name": "Stage III Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C91230"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIC Breast Cancer AJCC v7"
                ],
                "nci_thesaurus_concept_id": "C88377",
                "name": "Stage IIIC Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C88376"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Mammary Carcinoma",
                    "Carcinoma of Breast",
                    "Carcinoma of the Breast",
                    "Breast cancer, NOS",
                    "Cancer of Breast",
                    "Breast Carcinoma",
                    "Cancer of the Breast"
                ],
                "nci_thesaurus_concept_id": "C4872",
                "name": "Breast Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2916",
                    "C9335"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Glandular Cell Epithelium Neoplasm",
                    "Glandular Cell Epithelial Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7132",
                "name": "Glandular Cell Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Breast Disease",
                    "Breast Diseases"
                ],
                "nci_thesaurus_concept_id": "C26709",
                "name": "Breast Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor Morphology",
                    "Tumor_Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasms, NOS",
                    "Neoplasia",
                    "Tumor, NOS",
                    "Neoplastic Growth",
                    "Neoplasm",
                    "Neoplastic Disease",
                    "tumor",
                    "Neoplasm, NOS"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Malignant Epithelial Neoplasm",
                    "Epithelial Carcinoma",
                    "Malignant Epithelioma",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Epithelial tumor, malignant",
                    "Epithelioma Malignant"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C3709",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Disease",
                    "Diseases and Disorders",
                    "disease type",
                    "Disease or Disorder",
                    "Diagnosis",
                    "disease_term",
                    "condition",
                    "disease_type",
                    "Diseases",
                    "Disease or Disorder, Non-Neoplastic",
                    "Disorders",
                    "Disorder"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Malignant Growth",
                    "Tumor, malignant, NOS",
                    "Malignant Tumor",
                    "Malignancy",
                    "CA",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm of Breast",
                    "Neoplasm of the Breast",
                    "Tumor of Breast",
                    "Tumor of the Breast",
                    "Breast Tumor"
                ],
                "nci_thesaurus_concept_id": "C2910",
                "name": "Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3263",
                    "C26709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Tumor of the Breast",
                    "Malignant Neoplasm of the Breast",
                    "Malignant Neoplasm of Breast",
                    "Malignant Breast Tumor",
                    "Malignant Tumor of Breast"
                ],
                "nci_thesaurus_concept_id": "C9335",
                "name": "Malignant Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2910",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Adenocarcinoma, NOS",
                    "ADENOCARCINOMA, MALIGNANT"
                ],
                "nci_thesaurus_concept_id": "C2852",
                "name": "Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C7132"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma by AJCC v6 Stage"
                ],
                "nci_thesaurus_concept_id": "C90513",
                "name": "Breast Cancer by AJCC v6 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4872"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Secondary Malignancy",
                    "Secondary Cancer"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C36255"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C148124",
                "name": "Unresectable Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C27359"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Carcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C3482",
                "name": "Metastatic Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36310",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Unresectable Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C27359",
                "name": "Unresectable Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrence",
                    "Recurrent Cancer",
                    "Recurrent Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C4813",
                "name": "Recurrent Malignant Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C9305",
                    "C4798"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C170728",
                "name": "Metastatic Malignant Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9335",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Cancer",
                    "Relapsed Carcinoma",
                    "Relapsed Cancer"
                ],
                "nci_thesaurus_concept_id": "C7619",
                "name": "Recurrent Carcinoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4813",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma by AJCC v7 Stage"
                ],
                "nci_thesaurus_concept_id": "C91230",
                "name": "Breast Cancer by AJCC v7 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4872"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neoplasm, secondary",
                    "Secondary Tumor",
                    "Tumor, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36310",
                "name": "Secondary Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrence",
                    "Recurrent",
                    "Recurrent Tumor",
                    "Neoplasm Recurrence"
                ],
                "nci_thesaurus_concept_id": "C4798",
                "name": "Recurrent Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Tumor",
                    "Tumor, metastatic",
                    "Neoplasm, metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C170726",
                "name": "Recurrent Malignant Breast Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C9335",
                    "C4813"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "AAAP9506",
        "active_sites_count": 12,
        "lead_org_cancer_center": "Herbert Irving Comprehensive Cancer Center",
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2189",
                        "name": "Signal Transduction Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "CDK Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C2185",
                        "name": "Cyclin-Dependent Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C1404"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C64263",
                        "name": "Laboratory Biomarker Analysis",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C63333",
                            "C74957"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antiproliferative Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antiproliferative Drugs",
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Cancer Drug",
                            "Antineoplastics",
                            "Anti-Tumor Drugs",
                            "Antineoplastic Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Androstenedione Aromatase Inhibitor",
                            "Aromatase Inhibitor",
                            "Estrogen Synthase Inhibitor",
                            "Estrogen Synthetase Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C1740",
                        "name": "Aromatase Inhibition Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C129825",
                            "C481"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Agent",
                            "Enzyme Inhibitor Drug"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Kisqali"
                        ],
                        "nci_thesaurus_concept_id": "C95701",
                        "name": "Ribociclib",
                        "description": "An orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. CDK4/6 inhibitor LEE011 specifically inhibits CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation. Inhibition of Rb phosphorylation prevents CDK-mediated G1-S phase transition, thereby arresting the cell cycle in the G1 phase, suppressing DNA synthesis and inhibiting cancer cell growth. Overexpression of CDK4/6, as seen in certain types of cancer, causes cell cycle deregulation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2185",
                            "C129825"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Estrogen Inhibitor",
                            "Estrogen Antagonist",
                            "Antiestrogen Therapy Agent",
                            "Antiestrogens",
                            "Antiestrogenic",
                            "Anti-Estrogens",
                            "Antiestrogen"
                        ],
                        "nci_thesaurus_concept_id": "C481",
                        "name": "Antiestrogen Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129818",
                            "C547"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Quality of Life Assessment"
                        ],
                        "nci_thesaurus_concept_id": "C15584",
                        "name": "Quality-of-Life Assessment",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C15747"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Agent",
                            "Targeted Therapeutic Agent",
                            "Molecularly Targeted Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Hormonal Therapeutic",
                            "Antineoplastic Endocrinal Agent",
                            "Antineoplastic Hormonal Agent"
                        ],
                        "nci_thesaurus_concept_id": "C129818",
                        "name": "Antineoplastic Hormonal/Endocrine Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C147908",
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Enzyme Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C129825",
                        "name": "Antineoplastic Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129824",
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hormonal Therapy Agent",
                            "Hormone Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C147908",
                        "name": "Hormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Intervention Strategies",
                            "Procedure",
                            "Intervention"
                        ],
                        "nci_thesaurus_concept_id": "C25218",
                        "name": "Intervention or Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C16203"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1404",
                        "name": "Protein Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C63333",
                        "name": "Biomarker Analysis",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Therapeutic Technique",
                            "Therapeutic Method",
                            "Therapeutic Interventions",
                            "Therapy",
                            "TX"
                        ],
                        "nci_thesaurus_concept_id": "C49236",
                        "name": "Therapeutic Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antihormone Agents",
                            "Hormone Antagonist"
                        ],
                        "nci_thesaurus_concept_id": "C547",
                        "name": "Antihormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C147908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C74957",
                        "name": "Mixed Category Laboratory Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25294"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Test",
                            "Lab Tests",
                            "Laboratory Test",
                            "Tests",
                            "Lab Test"
                        ],
                        "nci_thesaurus_concept_id": "C25294",
                        "name": "Laboratory Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Femara"
                        ],
                        "nci_thesaurus_concept_id": "C1527",
                        "name": "Letrozole",
                        "description": "A nonsteroidal inhibitor of estrogen synthesis with antineoplastic activity.  As a third-generation aromatase inhibitor, letrozole selectively and reversibly inhibits aromatase, which may result in growth inhibition of estrogen-dependent breast cancer cells. Aromatase, a cytochrome P-450 enzyme  localized to the endoplasmic reticulum of the cell and found in many tissues including those of the premenopausal ovary, liver, and breast, catalyzes the aromatization of androstenedione and testosterone into estrone and estradiol, the final step in estrogen biosynthesis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2018"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C43431",
                        "name": "Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmaceuticals",
                            "Agent",
                            "Pharmacological Substance",
                            "Drug Substance",
                            "Pharmaceutical Agent",
                            "Drug",
                            "Pharmacologic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C16203",
                        "name": "Clinical or Research Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C43431"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Protein Inhibitor",
                            "Antineoplastic Protein Antagonist"
                        ],
                        "nci_thesaurus_concept_id": "C129824",
                        "name": "Antineoplastic Protein Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2189"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Non-Steroidal Androstenedione Aromatase Inhibitor",
                            "Non-Steroidal Estrogen Synthetase Inhibitor",
                            "Non-Steroidal Estrogen Synthase Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C2018",
                        "name": "Non-Steroidal Aromatase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1740"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Supportive Therapy",
                            "Therapy, Supportive",
                            "Symptom Management"
                        ],
                        "nci_thesaurus_concept_id": "C15747",
                        "name": "Supportive Care",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C49236"
                        ]
                    }
                ],
                "name": "Scenario 1 (ribociclib, letrozole)",
                "description": "Patients receive ribociclib PO QD on days 1-21 and letrozole PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients experiencing disease progression are then assigned to Scenario 2.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Faslodex"
                        ],
                        "nci_thesaurus_concept_id": "C1379",
                        "name": "Fulvestrant",
                        "description": "A synthetic estrogen receptor antagonist.  Unlike tamoxifen (which has partial agonist effects) and the aromatase inhibitors (which reduce the estrogen available to tumor cells), fulvestrant binds competitively to estrogen receptors in breast cancer cells, resulting in estrogen receptor deformation and decreased estrogen binding. In vitro studies indicate that fulvestrant reversibly inhibits the growth of tamoxifen-resistant, estrogen-sensitive, human breast cancer cell lines. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2116"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2189",
                        "name": "Signal Transduction Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Steroidal Estrogen Synthetase Inhibitors",
                            "Steroidal Androstenedione Aromatase Inhibitors",
                            "Steroidal Estrogen Synthase Inhibitors"
                        ],
                        "nci_thesaurus_concept_id": "C2017",
                        "name": "Steroidal Aromatase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1740"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Aromasin"
                        ],
                        "nci_thesaurus_concept_id": "C1097",
                        "name": "Exemestane",
                        "description": "A synthetic androgen analogue.  Exemestane binds irreversibly to and inhibits the enzyme aromatase, thereby blocking the conversion of cholesterol to pregnenolone and the peripheral aromatization of androgenic precursors into estrogens. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2017"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C64263",
                        "name": "Laboratory Biomarker Analysis",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C63333",
                            "C74957"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antiproliferative Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antiproliferative Drugs",
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Cancer Drug",
                            "Antineoplastics",
                            "Anti-Tumor Drugs",
                            "Antineoplastic Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Agent",
                            "Enzyme Inhibitor Drug"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Kisqali"
                        ],
                        "nci_thesaurus_concept_id": "C95701",
                        "name": "Ribociclib",
                        "description": "An orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. CDK4/6 inhibitor LEE011 specifically inhibits CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation. Inhibition of Rb phosphorylation prevents CDK-mediated G1-S phase transition, thereby arresting the cell cycle in the G1 phase, suppressing DNA synthesis and inhibiting cancer cell growth. Overexpression of CDK4/6, as seen in certain types of cancer, causes cell cycle deregulation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2185",
                            "C129825"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Androstenedione Aromatase Inhibitor",
                            "Aromatase Inhibitor",
                            "Estrogen Synthase Inhibitor",
                            "Estrogen Synthetase Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C1740",
                        "name": "Aromatase Inhibition Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C129825",
                            "C481"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "CDK Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C2185",
                        "name": "Cyclin-Dependent Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C1404"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Estrogen Inhibitor",
                            "Estrogen Antagonist",
                            "Antiestrogen Therapy Agent",
                            "Antiestrogens",
                            "Antiestrogenic",
                            "Anti-Estrogens",
                            "Antiestrogen"
                        ],
                        "nci_thesaurus_concept_id": "C481",
                        "name": "Antiestrogen Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129818",
                            "C547"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Quality of Life Assessment"
                        ],
                        "nci_thesaurus_concept_id": "C15584",
                        "name": "Quality-of-Life Assessment",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C15747"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Agent",
                            "Targeted Therapeutic Agent",
                            "Molecularly Targeted Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Hormonal Therapeutic",
                            "Antineoplastic Endocrinal Agent",
                            "Antineoplastic Hormonal Agent"
                        ],
                        "nci_thesaurus_concept_id": "C129818",
                        "name": "Antineoplastic Hormonal/Endocrine Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C147908",
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Enzyme Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C129825",
                        "name": "Antineoplastic Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129824",
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hormonal Therapy Agent",
                            "Hormone Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C147908",
                        "name": "Hormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Intervention Strategies",
                            "Procedure",
                            "Intervention"
                        ],
                        "nci_thesaurus_concept_id": "C25218",
                        "name": "Intervention or Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C16203"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1404",
                        "name": "Protein Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C63333",
                        "name": "Biomarker Analysis",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Therapeutic Technique",
                            "Therapeutic Method",
                            "Therapeutic Interventions",
                            "Therapy",
                            "TX"
                        ],
                        "nci_thesaurus_concept_id": "C49236",
                        "name": "Therapeutic Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antihormone Agents",
                            "Hormone Antagonist"
                        ],
                        "nci_thesaurus_concept_id": "C547",
                        "name": "Antihormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C147908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C74957",
                        "name": "Mixed Category Laboratory Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25294"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Test",
                            "Lab Tests",
                            "Laboratory Test",
                            "Tests",
                            "Lab Test"
                        ],
                        "nci_thesaurus_concept_id": "C25294",
                        "name": "Laboratory Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C43431",
                        "name": "Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmaceuticals",
                            "Agent",
                            "Pharmacological Substance",
                            "Drug Substance",
                            "Pharmaceutical Agent",
                            "Drug",
                            "Pharmacologic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Selective Estrogen Receptor Degrader",
                            "SERDs",
                            "SERD"
                        ],
                        "nci_thesaurus_concept_id": "C2116",
                        "name": "Selective Estrogen Receptor Down Regulator",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C481"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C16203",
                        "name": "Clinical or Research Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C43431"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Protein Inhibitor",
                            "Antineoplastic Protein Antagonist"
                        ],
                        "nci_thesaurus_concept_id": "C129824",
                        "name": "Antineoplastic Protein Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2189"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Supportive Therapy",
                            "Therapy, Supportive",
                            "Symptom Management"
                        ],
                        "nci_thesaurus_concept_id": "C15747",
                        "name": "Supportive Care",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C49236"
                        ]
                    }
                ],
                "name": "Scenario 2 Arm A (ribociclib, fulvestrant, exemestane)",
                "description": "Patients receive ribociclib PO QD on days 1-21. Patients also receive fulvestrant IM every 2 weeks for 6 weeks then every 4 weeks or exemestane PO daily on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Faslodex"
                        ],
                        "nci_thesaurus_concept_id": "C1379",
                        "name": "Fulvestrant",
                        "description": "A synthetic estrogen receptor antagonist.  Unlike tamoxifen (which has partial agonist effects) and the aromatase inhibitors (which reduce the estrogen available to tumor cells), fulvestrant binds competitively to estrogen receptors in breast cancer cells, resulting in estrogen receptor deformation and decreased estrogen binding. In vitro studies indicate that fulvestrant reversibly inhibits the growth of tamoxifen-resistant, estrogen-sensitive, human breast cancer cell lines. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2116"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2189",
                        "name": "Signal Transduction Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Steroidal Estrogen Synthetase Inhibitors",
                            "Steroidal Androstenedione Aromatase Inhibitors",
                            "Steroidal Estrogen Synthase Inhibitors"
                        ],
                        "nci_thesaurus_concept_id": "C2017",
                        "name": "Steroidal Aromatase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1740"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Aromasin"
                        ],
                        "nci_thesaurus_concept_id": "C1097",
                        "name": "Exemestane",
                        "description": "A synthetic androgen analogue.  Exemestane binds irreversibly to and inhibits the enzyme aromatase, thereby blocking the conversion of cholesterol to pregnenolone and the peripheral aromatization of androgenic precursors into estrogens. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2017"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C64263",
                        "name": "Laboratory Biomarker Analysis",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C63333",
                            "C74957"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Androstenedione Aromatase Inhibitor",
                            "Aromatase Inhibitor",
                            "Estrogen Synthase Inhibitor",
                            "Estrogen Synthetase Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C1740",
                        "name": "Aromatase Inhibition Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C129825",
                            "C481"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Agent",
                            "Enzyme Inhibitor Drug"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antiproliferative Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antiproliferative Drugs",
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Cancer Drug",
                            "Antineoplastics",
                            "Anti-Tumor Drugs",
                            "Antineoplastic Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Estrogen Inhibitor",
                            "Estrogen Antagonist",
                            "Antiestrogen Therapy Agent",
                            "Antiestrogens",
                            "Antiestrogenic",
                            "Anti-Estrogens",
                            "Antiestrogen"
                        ],
                        "nci_thesaurus_concept_id": "C481",
                        "name": "Antiestrogen Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129818",
                            "C547"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Quality of Life Assessment"
                        ],
                        "nci_thesaurus_concept_id": "C15584",
                        "name": "Quality-of-Life Assessment",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C15747"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Agent",
                            "Targeted Therapeutic Agent",
                            "Molecularly Targeted Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Hormonal Therapeutic",
                            "Antineoplastic Endocrinal Agent",
                            "Antineoplastic Hormonal Agent"
                        ],
                        "nci_thesaurus_concept_id": "C129818",
                        "name": "Antineoplastic Hormonal/Endocrine Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C147908",
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Enzyme Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C129825",
                        "name": "Antineoplastic Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129824",
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Hormonal Therapy Agent",
                            "Hormone Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C147908",
                        "name": "Hormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Intervention Strategies",
                            "Procedure",
                            "Intervention"
                        ],
                        "nci_thesaurus_concept_id": "C25218",
                        "name": "Intervention or Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C16203"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C63333",
                        "name": "Biomarker Analysis",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Therapeutic Technique",
                            "Therapeutic Method",
                            "Therapeutic Interventions",
                            "Therapy",
                            "TX"
                        ],
                        "nci_thesaurus_concept_id": "C49236",
                        "name": "Therapeutic Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antihormone Agents",
                            "Hormone Antagonist"
                        ],
                        "nci_thesaurus_concept_id": "C547",
                        "name": "Antihormone Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C147908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C74957",
                        "name": "Mixed Category Laboratory Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25294"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Test",
                            "Lab Tests",
                            "Laboratory Test",
                            "Tests",
                            "Lab Test"
                        ],
                        "nci_thesaurus_concept_id": "C25294",
                        "name": "Laboratory Procedure",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C25218"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C43431",
                        "name": "Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C116558",
                        "name": "Placebo Administration",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C49236"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmaceuticals",
                            "Agent",
                            "Pharmacological Substance",
                            "Drug Substance",
                            "Pharmaceutical Agent",
                            "Drug",
                            "Pharmacologic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Selective Estrogen Receptor Degrader",
                            "SERDs",
                            "SERD"
                        ],
                        "nci_thesaurus_concept_id": "C2116",
                        "name": "Selective Estrogen Receptor Down Regulator",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C481"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C16203",
                        "name": "Clinical or Research Activity",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C43431"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Protein Inhibitor",
                            "Antineoplastic Protein Antagonist"
                        ],
                        "nci_thesaurus_concept_id": "C129824",
                        "name": "Antineoplastic Protein Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2189"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Supportive Therapy",
                            "Therapy, Supportive",
                            "Symptom Management"
                        ],
                        "nci_thesaurus_concept_id": "C15747",
                        "name": "Supportive Care",
                        "description": null,
                        "type": "Other",
                        "category": "other",
                        "parents": [
                            "C49236"
                        ]
                    }
                ],
                "name": "Scenario 2 Arm B (placebo, fulvestrant, exemestane)",
                "description": "Patients receive placebo PO QD on days 1-21 and fulvestrant IM or exemestane PO as in Arm A. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity.",
                "type": "ACTIVE_COMPARATOR"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2016-01092",
        "why_study_stopped": null,
        "brief_summary": "This randomized, phase II trial studies how well fulvestrant or exemestane with or without ribociclib works in treating patients with hormone receptor positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer that has progressed after treatment with an aromatase inhibitor or cyclin-dependent kinase 4/6 inhibitor (recurrent), cannot be removed by surgery (unresectable), or has spread to other parts of the body (metastatic). Hormone therapy using fulvestrant or exemestane may fight breast cancer by blocking the use of estrogen by the tumor cells or reducing the amount of estrogen made by the body. Ribociclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving fulvestrant or exemestane with ribociclib may be an effective treatment for patients with breast cancer.",
        "brief_title": "Fulvestrant or Exemestane with or without Ribociclib in Patients with Recurrent, Unresectable, or Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer",
        "status_history": [
            {
                "status_date": "2016-05-05T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 120,
        "_current_trial_status_sort_order": 0,
        "start_date": "2016-05-05",
        "record_verification_date": "2021-09-02",
        "ctep_id": null,
        "current_trial_status": "Active",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": "DOUBLE_BLIND",
            "role_investigator": "INVESTIGATOR",
            "role_outcome_assessor": null,
            "role_subject": "SUBJECT",
            "allocation_code": "Randomized Controlled Trial"
        },
        "acronym": null,
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Breast"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": "Melissa K. Accordino",
        "study_source": "Institutional",
        "completion_date": null,
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]